# Single and Multiple Ascending Dose Study and Food Effect Study for AG181

> **NCT06286033** · PHASE1 · COMPLETED · sponsor: **Agios Pharmaceuticals, Inc.** · enrollment: 88 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** AG-181
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06286033
- **Lead sponsor:** Agios Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-02-20
- **Primary completion:** 2025-10-09
- **Final completion:** 2025-10-09
- **Target enrollment:** 88 (ACTUAL)
- **Last updated:** 2025-12-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06286033

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06286033, "Single and Multiple Ascending Dose Study and Food Effect Study for AG181". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06286033. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*